Research to Prevent Blindness (RPB) provides major eye research funding to more than 50 leading scientific institutions in the U.S. and supports the work of hundreds of talented vision scientists engaged in a diverse range of disease-oriented research.
RPB's funding for vision research reached $10.7 million in 2014, as Research to Prevent Blindness (RPB) completed it's final round of grant making...
FDA approves artificial retina for use in the United States:
The idea that stem cells – the precursors of all body tissues – could be turned into organ replacements for diseased body parts has tantalized physicians and patients for decades.
March 24, 2015, Washington, DC -- Top execs from major eye research funding organizations convened in Washington, DC for a second time to advance an agenda for collaborative action in addressing key issues facing...
RPB-supported researchers at the University of Southern California (USC) report that ranibizumab (sold as Lucentis) can help Hispanic and non-Hispanic whites with diabetic macular edema (DME) in the United States...
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
General Info | Research Scientists & Grantees | Eye Care Specialists | Donors & Partners |